Clinical Trials Browser

Completed × Rhabdomyosarcoma × Everolimus × Clear all

NCT03245151 2023-08-30

Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors

Phase 1/2 Completed

64 enrolled 29 charts

Glioma, Recurrence, Rhabdomyosarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral

NCT00187174 2015-03-04

Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors

Phase 1 Completed

Brain Neoplasms, Neoplasms, Recurrence, Rhabdomyosarcoma, Sarcoma